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 INTRODUCTION 
   In patients with endocrine disorders there is a high prevalence of 
mood disorders in general and particularly major depression. Specifically 
regarding thyroid diseases, according to Boswell et al.,(1997), the 
prevalence of depressive symptoms is quite higher ranging from (30–50%) 
where as in patients primarily diagnosed with major depression, there is 
rarely a picture of overt thyroid dysfunction. 
 Although, a relationship between clinical disorders of the thyroid 
gland and depression has been well established, the significance of the 
association between thyroid function and major depression is much less 
clear. Hence the possibility of a relationship between thyroid gland, brain 
and depression has been of interest to both clinicians and researchers for 
more than two centuries. 
 According to  Joffe et al.,(1990), the reviews on various studies have 
yielded a conflicting data in thyroid functioning in acute depression, 
however the most consistent findings have been elevated total thyroxin(T4) 
or free thyroxin(FT4) within “the euthyroid range” that decreases with 
treatment for depression. 
 In India, very little work has been done in this field. Chopra VK et 
al.,(2001)  has done a study on basal thyroid function in depressive illness 
and concluded that total thyroxin(T4) levels were elevated in the drug naïve 
first episode depressive patients as compared to health controls. This is in 
agreement with most of the earlier studies (Whybrow et al., 1972; Takahashi 
et al., 1974; Kierkegaard and Faber, 1981; Muller and Boning, 1988). 
Scope of the Study : 
 Even though a lot of studies were done in this field World wide, In 
south India the studies are limited and also there are conflicting datas on 
thyroid function in acute depression. Hence there is an utmost need to 
evaluate the basal thyroid function in major depression. So the present study 
was conducted to evaluate the basal thyroid functions in drug naïve patients 
with first episode of depression and to compare the findings with the normal 
controls. 
 
 
 
 
 
 REVIEW OF LITERATURE 
I. Thyroid gland: 
i) Anatomy: Thyroid is an endocrine gland, situated in the lower part of the 
front and sides of the neck. The gland consists of right and left lobes that are 
connected by the isthmus. 
 The gland consists of numerous acini or follicles about 200 microns 
in diameter. Each follicle is lined by cuboidal epithelium, whose height 
varies with the degree of glandular activity. Each follicle contains colloid 
which normally compromises iodinated ‘thyroglobulin’. Between the 
follicles are ‘para follicular cells’ also called as ‘C-cells’. Follicular cells 
produces T3,T4 and reverseT3.Para follicular cells produces calcitonin. 
ii)Physiological aspects of thyroid hormone: 
 Thyroid hormones T4, T3 and reverse T3 are synthesized by the 
iodination of tyrosine residues of thyroglobulin and are stored in the thyroid 
follicles. The thyroglobulin molecule is a glycoprotein synthesize by the 
thyroid cells.  Thyroxin (T4) is tetraiodothyronine, while T3 is 
triiodothyronine. 
 
 SYNTHESIS, STORAGE AND RELEASE OF THYROID 
HORMONES: 
1.IODIDE UPTAKE: Thyroid cells traps iodide from blood by an active 
transport process, stimulated by the thyroid stimulating hormone(TSH) of 
the anterior pituitary gland. 
2. OXIDATAION AND IODINATION: Iodide trapped by the follicular 
cells is oxidized by peroxidase enzyme to form iodine which combines with 
tyrosine residues of thyroglobulin to form monoiodotyrosine(MIT) and 
diiodotyrosine(DIT). 
3. COUPLING: Pairs of iodinated tyrosine residues couple together to form 
T4, T3 and reverse T3 by an oxidative reaction. 
4. STORAGE AND RELEASE: The thyroglobulin containing iodinated 
tyrosine residues, remains stored as colloid in the follicles. When the gland 
become active colloid is taken back into the follicular cells and release 
T3,T4 and reverse T3 into the circulation. 
5. PERIPHERAL CONVERSION OF T4 TO T3: Peripheral tissues like 
liver, kidney and muscle convert T4 into T3 by mono deiodination. About 
85 % of T3 is produced by this way. Although the circulating levels of T3 
are much lower than the T4 levels, T3 is the metabolically active hormone. 
However T4 is the main determinant of the thyroid hormone available to the 
brain, T4 crosses the blood brain barrier and converted to T3 within their 
own cells. 
TRANSPORT OF THYROID HORMONES: Within the plasma T3 and 
T4 are transported bound to plasma protein thyroxine –binding globulin 
(TBG), so that only 0.3% of T3 and 0.02 % of T4 are free. 
REGULATION OF THYROID HORMONE SECRETION:  
 Thyroid stimulating hormone (TSH) produced by the anterior 
pituitary gland regulates the synthesis and release of thyroid hormones. It is 
in turn stimulated by thyrotropin releasing hormone (TRH) produced in the 
hypothalamus and inhibited by high blood levels of thyroid hormones T3 
and T4. TSH secretion has a circadian rhythm with an increase near to 
midnight (between 10 PM and 4 AM). 
iii) BIOLOGICAL EFFECTS OF THYROID HORMONE: 
a. METABOLIC ACTIONS: 
1. EFFECT OF PROTEIN METABOLISM: The overall effect of T4 
is catabolic, that is increased amount of protein being used as energy, 
so prolonged action results in negative nitrogen balance and tissue 
wasting. 
2. EFFECT ON CARBOHYDRATE METABOLISM: The net effect 
on carbohydrate metabolism is increase in blood sugar, the thyroid 
hormones are antagonistic to insulin. 
3. EFFECT ON LIPID METABOLISM: T4 and T3 enhance lipolysis 
and at the same time also stimulates lipogenesis. It accelerates all 
phases of cholesterol metabolism, but its conversion to bile acids 
dominates. 
b. GROWTH AND DEVELOPMENT: T3 and T4 are essential for 
normal growth and development, so their congenital deficiency 
results in cretinism. Thyroid hormones are essential for axonal and 
dentritic ramification, synapse formation and myelination.  
c. CALORIGENESIS: T3 and T4 increases basal metabolic rate 
(BMR) by stimulation of cellular metabolism. 
d. NERVOUS SYSTEM: T3 and T4 have profound functional effect 
on CNS. Mental retardation occurs in cretinism. Sluggishness and 
other behavioral features occurs in myxoedema. Hyperthyroid 
individuals are anxious, exhibit tremors and hypereflexia. 
Peripheral Nervous system: The reaction time of “stretch reflexes” is 
shortened in hyper thyroid and prolonged in hypothyroidism. 
II. DISORDERS OF THYROID FUNCTION: 
 Thyroid dysfunction can be evaluated by thyroid function tests. 
1. TSH test: 
 A high TSH level indicates that the thyroid gland is failing 
because of a problem that is directly affecting the thyroid (primary 
hypothyroidism). 
 A low TSH level indicates that the thyroid is overactive 
producing excess thyroid hormone (hyperthyroidism). 
 Occasionally a low TSH may result from an abnormality in the 
pituitary gland, which prevent it from making enough TSH to 
stimulate thyroid gland (secondary hypothyroidism). 
 In most healthy individuals, a normal TSH value means that the 
thyroid is functioning normally. 
 Normal TSH level: 0.3 to 4.7 mIU/L. 
2. T4 (thyroxine test):  T4 circulates in the blood in two forms: 
i. T4 bound to proteins that prevent T4 from entering 
various tissues that need thyroid hormone. 
ii. Free T4 enter the various target tissues to exert its effect. 
The free T4 fraction is the most important test to assess thyroid 
function and tests to measure this is called free T4 (FT4) and Free T4 
index (FT4I). 
A low TSH with an elevated FT4 or FTI is found in hyperthyroidism. 
A low TSH with low FT4 or FTI indicates hypothyroidism due to 
problem involving the pituitary gland. 
A high TSH with low FT4 or FTI indicates primary hypothyroidism 
due to disease in thyroid gland. 
Normal serum thyroxine : 4.6 – 12 µg/dl. 
Free thyroxine FT4 : 0.7 – 1.9 µg/dl 
Free T4 index FT4I : 4.6 – 12. 
3. T3 (Triiodothyronine) test: T3 are often useful for diagnosis of 
hyperthyroidism or determine the severity of the hyperthyroidism. 
A low TSH level with high T3 levels occurs in 
hyperthyroidism. 
A high TSH level with low T3 levels occurs in hypothyroidism. 
However T3 testing is  rarely helpful in hypothyroid patients, 
as it is the last test to become abnormal. 
 Normal Serum Triiodothyronine T3: 80 – 180ng/dl. 
                                  FreeT3 index FT3I:80-180. 
INTERPRETATION OF RESULTS 
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T4 
 
T3 
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High Low Low or Normal Hypothyroidism 
Low 
High or 
Normal 
High or Normal Hyperthyroidism 
Low 
Low or 
Normal 
Low or Normal 
Pitutary (secondary 
hypothyroidism) 
High Normal Normal 
Sub clinical 
Hypothyroidism. 
 
4. TRH stimulation test (Thyrotropin Releasing Hormone): It is 
sometimes used in the workup of the thyroid function. The procedure 
involves intra venous (IV) injection of 500 mg of TRH, which 
produces a sharp rise in serum TSH when measured at 15, 30, 60 and 
90 minutes. A normal response is a rise in TSH of 5 microu/ml or 
more above the base line level. In hypothyroid patients, the response 
is exaggerated, whereas in hyperthyroid patients it is blunted. Its use 
as a diagnostic tool in the psychiatric assessment of depression has 
waned as its specificity and sensitivity are poor. For example, 
although some patients with depression experience elevation of TSH 
often following TRH infusion, others have a blunted response. 
5. THYROID ANTIBODY TEST: In many patients with 
hypothyroidism or hyperthyroidism, lymphocytes makes antibodies 
against thyroid that stimulate or damage the gland. Two common 
antibodies that cause thyroid problems are against thyroid peroxidase 
and thyoglobulin. Measuring of thyroid antibodies may help diagnose 
the cause of thyroid problems. 
Thyroid peroxidase antibody or Anti microsomal antibody (TPO Ab): 
This antibody is present in Grave’s disease, Hashimoto’s thyroiditis. 
Thyroglobulin antibody (TgAb):This antibody is present in thyroid 
cancer, Hashimoto’s thyroiditis. 
TSH Receptor antibody: This antibody is present in Grave’s disease. 
III.NEUROPSYCHIATRIC ASPECTS OF THYROID 
DYSFUNCTION: 
 Disorders of thyroid gland falls into two general categories: 
 Hyperthyroidism or Hypothyroidism 
 
A) Hypothyroidism:  
It results from inadequate synthesis of thyroid hormone and is 
categorized as overt or subclinical. 
Overt (Grade 1) Hypothyroidism : These patients have classical 
signs and symptoms of hypothyroidism. Lab values show decreased 
T4 and elevated TSH and increased TSH response to TRH. 
Subclinical Hypothyroidism (SCHT) : These patients are by 
definition, asymptomatic with normal thyroid hormone levels but 
elevated TSH. They are graded as follows: (Gold et al.,1981) 
Grade 2 Hypothyroidism: These patients have normal T3 and T4 
but elevated TSH and increased TSH response to TRH. 
Grade 3 Hypothyroidism: These patients have normal T3 and T4 
and TSH, but increased TSH response to TRH. 
The most common cause of hypothyroidism in adults is 
Hashimoto’s thyroiditis. Other causes of hypothyroidism includes 
idiopathic atrophy, endemic hypothyroidism from deficiency of 
dietary iodine, hypopitutarism (from post partum pituitary neurosis), 
hypothalamic disease resulting from deficient production of TRH and 
iatrogenic hypothyroidism (caused by drugs such as Lithium or Anti 
thyroid drugs or from surgical or chemical thyroidectomy). 
Epidemiology: The prevalence of overt hypothyroidism is approximately 
2% in women and less than 0.1 percent in men. SCHT predominates in 
women, occurring in approximately 7.5% of women and 3% in men. 
Women appear to have higher rates of hypothyroidism because of their 
greater rates of auto immune disease. As the prevalence of auto immune 
disease rises with age, the prevalence of overt and SCHT also rises with age, 
particularly in women. 
Physical features: Signs and symptoms includes cold intolerance, 
constipation, paresthesias, muscle cramps, menstrual disturbances 
(amenorrhea or menorrhagia), reduced hearing, weight gain, brittle and thin 
hair, husky voice, slowed deep tendon reflexes (DTR), bradycardia, 
cardiomegaly, low voltage complexes on ECG, elevated levels of cholestrol 
and triglycerides and normochromic and normocytic anemia.  
Neuropsychiatric features: 
Cognitive disturbances: includes the inability to concentrate, poor 
attention, bradyphrenia, calculation difficulties and difficulty understanding 
complex questions and memory impairment. 
Depressive syndrome: Depressive affect has been reported as a frequent 
association with hypothyroidism Whybrow et al.,(1969). Several of the 
metabolic and behavioral changes seen in hypothyroidism are common to 
depression, suggesting the changes in the pituitary-thyroid axis system may 
play a role in the modulation  of mood. 
 The most common abnormality in thyroid function testing among 
patients with depression is a mild elevation in serum thyroxine 
concentration, which falls with clinical response to treatment (Whybrow and 
Bauer 2000). 
Serum TSH response to thyrotropin- releasing hormone is blunted in 
25% of depressed patients and nocturnal surge  of TSH is lost in depression, 
returning to normal with recovery (Whybrow and Bauer 2000). 
Psychosis: A psychotic syndrome of auditory hallucinations and paranoia 
named myxedema madness, has been described in some patients. 
SCHT: may produce depressive symptoms and cognitive deficits, although 
these tend to be less severe than those produced by overt hypothyroidism. 
Among patients with SCHT, the lifetime prevalence of depression in 
patients is approximately double that of the general population. A lower 
response rate to antidepressants has been observed among patients with 
SCHT, in addition to greater likelihood to respond to T3 augmentation as 
compared to euthyroid depressed patients. 
B. Hyperthyroidism: Hyperthyroidism or thyrotoxicosis results from over 
production of thyroid hormones by the thyroid gland. The most common 
cause is Graves disease. Toxic nodular goiter causes another 10% of cases 
among middle aged and elderly patients. Other causes include hyper 
functioning solitary thyroid adenomas, thyroiditis, use of exogenous thyroid 
hormones, TSH- producing pituitary adenomas, pituitary resistance of 
suppression of TSH, secretion by the thyroid hormone, thyroid carcinoma, 
choriocarcinoma, hydatiform moles and struma ovarii. 
 Thyroid storm (thyrotoxic crisis) is a life threatening syndrome that is 
usually precipitated by illness or injury but also develops after withdrawal 
from anti thyroid drugs or often therapy with RAI (Radio active Iodine). 
Symptoms include marked tachycardia, weakness, fever and altered mental 
status. 
Epidemiology: In the general population, the presence of hyperthyroidism 
is approximately 0.5%. Graves disease is the most common cause, 
accounting for 80% of cases. Graves disease occurs four times more 
frequently in women than men. The prevalence of thyroiditis is estimated to 
occur in 5 to 9 % of women in the post partum period, usually resolving 
spontaneously by one year after delivery. 
Physical features: Signs and symptoms of hyperthyroidism include 
increased pulse rate, arrhythmias, elevated blood pressure, fine tremor, heat 
intolerance, excessive sweating, increased appetite, weight loss, palpitation, 
tachycardia, menstrual irregularities, muscle weakness, exopthalmous, lid 
lag, hyper active deep tendon reflexes. 
Cognitive symptoms: It includes a short attention span, impaired recent 
memory and exaggerated startle response. 
Psychiatric features : it includes nervousness, fatigue, insomnia, mood 
liability and dysphoria. 
In several cases, there may be visual hallucinations, paranoid ideation 
and delirium. Although some symptoms of hyperthyroidism resembles that 
of a manic episode, an association between hyperthyroidism and mania has 
rarely been observed. 
C. POST PARTUM THYROIDITIS: 
 Post partum thyroiditis is a common thyroid disorder that presents 
during the first post partum year. It is the occurrence of either transient 
hyperthyroidism, transient hypothyroidism, or transient hyperthyroidism 
followed by transient hypothyroidism. 
Etiology: Post partum thyroiditis is an exaberation of an underlying auto 
immune thyroiditis, aggravated by the immunological rebound that follows 
the partial immunosuppression of pregnancy. Prevalence of post partum 
thyroiditis ranges between 1.15 and 16.7% with a mean prevalence of 7.2%. 
Clinical features: Symptoms can occur during either phase of post partum 
thyroiditis. 
The hyperthyroid phase presents with palpitation, fatigue, heat 
intolerance, irritability and nervousness. This phase is diagnosed by the 
combination of low serum TSH concentration in the presence of thyroid 
peroxidase antibodies. In women who are TSH receptor antibody- negative, 
free T4 levels are typically elevated but may be normal. 
 The hypothyroid phase of thyroiditis presents with impaired 
concentration , poor memory, decreased energy and dry skin. An elevated 
TSH in the presence of antithyroid peroxidose antibody is pathognomic for 
post partum thyroiditis. 
Post partum depression: Studies evaluating the association between post 
partum thyroiditis and post partum depression have yielded varying results. 
Investigations have evaluated both the impact of hypothyroidism and the 
presence of thyroid antibodies (antithyroid preoxidase and for 
antithroglobulin) on the development of post partum depression. Two 
studies by Hayslip CC., et al 1988 & PopVJM., et al 1991 reported an 
association between hypothyroidism and post partum depression, whereas 
two other study reports by Harris B., et al 1992 & Kujipens., et al 2001 
discovered an increased rate of depression in euthyroid women ,who were 
thyroid antibody positive during post partum. One study by Kent GN ., et al 
1999 found no correlation. 
IV. DEPRESSION AND THYROID DYSFUNCTION 
1. DEPRESSION AND THE HYPOTHALAMUS-PITUTARY- 
THYROID AXIS: 
The link between mood disorders and abnormalities of the HPT axis can 
be studied by the assessment of functional thyroid tests in patients with 
primary mood disorder. It has been argued that depression might be 
characterized by a ‘low-thyroid function syndrome’ (Legros et al. 1985; 
Staner et al. 1992; Rao et al. 1996). Hypothyroidism is associated with 
refractory depression, suggesting that this characterizes one biological 
subtype of refractory depression. 
Screening thyroid tests are often routine for depressed inpatients, but 
data suggest that thyroid screening may add little to the diagnostic 
evaluation. Overt thyroid disease is rare among depressed inpatients (Ordas 
and Labbate 1995), and the role of thyroid hormones in the pathophysiology 
of affective disorders remain to be clarified (Joffe and Sokolov 1994). 
A) T4 (Thyroxine) : According to (Jackson., et al 1999) he concluded 
that most patients with depression, although generally viewed as 
chemically enthyroid, have alteration in their thyroid function. It 
includes 
1. Slight elevation of serum thyroxine (i.e within the normal 
range) 
2. Blunted thyrotropin response to TRH stimulation 
3. Loss of nocturnal TSH rise. 
These changes were generally reversed following alleviation of the 
depression. He postulated that hypercortisolism of depression (which occurs 
due to impaired functioning of the hippocampus, which is the negative feed 
back site of glucocorticoids, along the hypothalamic hypophyseal adrenal 
axis) lead to an activation of the hypothalamic neurons which produces 
TRH and consequently the increase of T4. The increased TRH secretion 
may lead to down regulation of the TRH receptor leading to blunted TSH 
response to TRH stimulation. 
According to Bauer and Whybrow 1988, in some cases of depression 
the brain would be TH deficient and the relative increase of thyroxine would 
exert a compensatory role in the maintenance of the “affective 
homeostasis”, offering more T4 for the brain with deficiency of this 
hormone, seeking to normalize function. 
A review by Musselman., et al 1998 concerning the HPT axis, 
depressed patients have been reported to have: 
1. Alteration in the thyroid stimulating hormone response to thyrotropin-
releasing hormone (TRH) 
2. An abnormally high rate of antithyroid antibodies; and  
3. Elevated cerebrospinal (CSF) TRH concentrations. 
Hence with regard to T4 most of the studies of major depressive disorder 
have found an relative increase (i.e within the normal range) of 
iodothyronines, mostly notably hyperthyroxinemia (i.e serum FT4, total 
T4). Neuro biologically, this thyroid activation has been proposed to 
represent a compensatory mechanism to a pathological process, that is 
depression or the primary pathology itself. 
 
B. T3 (Triiodothyronine): 
 With regard to Triiodothyronine (T3) Kirkegaard and Faber et al., 
(1986) have found no alterations in the free T3 serum levels in depressed 
patients. In one study by Kirkegaard et al.,(1990) the daily production of T3 
among non medicated and moderately depressed subjects was within the 
normality. It raises the hypothesis that the combination of the production of 
increased T4 with the production of normal T3 suggest a conversion of T4 
into reduced T3 caused by the reduction in the enzymatic activity of 
deiodination, probably in the brain. 
 It has been proposed by (Nemeroff., et al 1989) that in depression 
there is an inhibition of the 5’-deiodinase type II (D-II) enzyme, probably 
due to the increase in cortisol levels. This enzyme is responsible for the 
transformation of T4 into active T3 in the brain, consequently its inhibition 
triggers the conversion of T4 by type III brain 5’–deiodinase (D-III) , 
producing reverse T3 (rT3). A defect in brain deiodinase can be a 
pathogenic factor in depression, raising the possibility of central or brain 
hypothyroidism. 
C.TSH : with regard to thyrotrophin (TSH) Cleare et al.,(1996) found a 
positive relation between depressive scores and the increase in TSH levels, 
confirming the previous findings of this same group. A probable hypothesis 
for the increase in serum TSH in depression stems from the observation that 
the plasma level of this hormone is influenced by somatostatin, which 
inhibits TSH release from the hypophysis.  In some studies (Rubinow DR et 
al., 1983 &Bissette G et al.,1986),they found a reduction in somatostatin in 
the CSF of depressed subjects, which may contribute for the increase of 
serum TSH in depressive conditions. 
           Although plasma TSH levels in depressed patients are not conclusive, 
A Study by (Bartalena et al.,1990)concluded that endogenous major 
depression is associated with an important impairment in the nocturnal 
secretion of TSH, being a more sensitive alteration of the HPT axis in 
endogenous depression than the TRH challenge test. 
 This nocturnal reduction in TSH can lead to global decrease in the 
secretion of thyroid hormone, enabling a certain degree of central 
hypothyroidism in some depressed patients. 
D. Response of TSH to TRH:  Prange.,et al.(1972) in patients with major 
depression, observed the presence of decreased response of TSH to TRH 
stimulation in 25 % of these cases and all these patients had normal TSH, 
T3 and T4 plasma levels. Still in the same year Kastin AJ et al.,(1972) 
confirmed those data, afterwards reconfirmed  by other studies which 
defined this decreased TSH response to TRH as the most widely recognized 
evidence of thyroid axis abnormality in depression. This decrease or blunted 
response to TSH occurs in 25 to 30 % of depressive individuals. 
 On the other hand, there are studies with depressed patients which 
found an increased TSH response to TRH (Extein I et al.,(1982) & Gold MS 
et al.,(1981).It is calculated that nearly 10 to 17 % of depressed individuals 
showed an exaggerated response to the test (Nemeroff CB.1989 & Gold MS 
et al.,1981). These cases use to have normal TSH, T3, T4 plasma levels, the 
so called ‘grade III hypothyroidism’. In 1982, Gold., et al found 60 % of 
cases with positive anti thyroid antibodies among depressed patients with 
exaggerated response to TRH, being the first report that some depressive 
pictures show high rates of asymptomatic auto immune thyroiditis. 
 Recently Kraus et al.,( 199 7) investigated 60 depressed patients and 
concluded that mild alteration in thyroid function may contribute for 
depression in some cases and utilization of the TRH challenge test as the 
most sensitive one to investigate the thyroid alterations which could 
contribute to the depressive picture and / or hamper their recovery. 
E. Thyrotropin-releasing hormone(TRH): 
 Banki et al .,(1988) assessed brain TRH among depressive and manic 
pictures and among controls. Depressed patients showed an increase in TRH 
levels nearly three fold than controls. This chronic stimulation of TRH in 
the hypophysis could be responsible for the TSH and T4 serum alterations 
found in depressed patients. 
 
Blood Brain Barrier and TH transportation: 
Transthyretin (TTR): It is one of the T4 serum transporting protein. Only 
one study has investigated this protein in depressive disorders, and have 
found significantly decreased levels of TTR among patients with refractory 
major depression as compared to the control group, and the authors have 
suggested that the low levels of this transporting protein may cause ‘brain 
hypothyroidism’, accompanied by peripheral concentration of thyroid 
hormones within the normal range (Hatterer JA., et al.1993). With the lower 
availability of thyroid hormones in the brain, there is an increase in the 
hypothalamus production of TRH, resulting in increased values of TRH in 
the CSF and an decreased response of TSH to TRH. The authors suggest 
that a thyroid dysfunction may represent a pathophysiological phenomenon 
in a sub group of depressed patients. 
2. TYPES OF DEPRESSION AND THYROID DYSFUNCTION 
a. POST PARTUM DEPRESSION: The most robust relationship 
between thyroid dysfunction and depression is in the post partum period. 
They found that women who have underlying sub clinical auto immune 
disease may get exacerbation following delivery, leading to the production 
of thyroid antibodies which may cause thyroid dysfunction either overt or 
latent hypothyroidism leading to depression. However again the literature is 
split and the results are inconclusive. 
b. ENDOGENOUS DEPRESSION: A study by Bartalena et al., 
(1990). noted that patients with endogenous major depression had an 
impairment in the nocturnal secretion of TSH which is an sensitive 
alteration in the HPT axis. This nocturnal reduction in TSH can lead to 
global decrease in the secretion of thyroid hormone, enabling a certain 
degree of central hypothyroidism in these patients.  
c. SEVERE DEPRESSION WITH PSYCHOTIC FEATURES: A 
study by Vinod kumar., et al. 2001 found there was no significant 
difference between depressive patients with and without the presence of 
psychotic features and with and without the presence of somatic syndrome 
with respect to total T3 and total T4. However depressive patients with 
psychotic features had significantly higher mean value of thyroid 
stimulating hormone (TSH) as compared to those without psychotic 
features. 
            Joffe., et al 1992 did not find any difference between patients with 
melancholic and non melancholic depression with respect to total 
thyroxinT4,total triiodothyronine T3 and thyroid stimulating hormone 
TSH.Joffe and Levitt 1990 found significantly lower total tiriodothyronine 
T3 and significantly higher thyroid stimulating hormone TSH in patients 
with psychotic depression compared to non psychotic depression. 
     An exploratory study on thyroid function in clinical subtypes of major 
depression was done by Fountaulakis et al.,(2004) he concluded that no 
significant differences can be traced concerning the thyroid function 
between clinical subtypes of depression nor there is any correlation 
between specific clinical symptoms and thyroid indices. 
3. DEPRESSION AND THE AUTO IMMUNE HYPOTHESIS: 
The hypothalamus-pituitary-thyroid axis (HPT) is not isolated from 
the rest of the endocrine system, and it is heavily influenced by auto 
immune disorders and stress. 
Any significant changes in the stress system activity, such as acute or 
chronic stress or even cessation of chronic stress, severe exercise, 
pregnancy, the post partum period, anxiety and mood disorders may 
suppress or potentiate auto immune disease activity and/or progression 
through modulation of the systemic or local pro/ anti inflammatory cytokine 
balance (Elenkov and Chrousos.2002). 
Musselman and Nemeroff (1996), reported that depressed patients 
had an abnormally high rate of anti thyroid antibodies. Gold et al., (1982) 
found that auto immune thyroiditis was found in 15 % of depressed patients 
with exaggerated response to the TRH stimulation test. 
The finding that depression often co-exists with auto immune 
subclinical thyroiditis suggests that depression may cause alterations in the 
immune system, or that in fact it could be an auto immune disorder itself. 
It is also believed (although not well documented) that depression is 
accompanied by various direct and indirect indicators of a moderate 
activation of the inflammatory response system. Increased production of 
proinflammatory cytokines, such as Interleukin-1, Interleukin-6 and 
Interferon (IFN-8) may play a crucial role in the immune and acute phase 
response in depression (Van west and Maes.1999). 
How ever, the research in the area of psycho immunology is very 
delicate and one should be very careful in interpreting results. Apart from 
problems arising from the limitations in laboratory techniques themselves, 
depressed patients may suffer from secondary alterations of immune 
function, while controls may be ‘super-normal’. 
 
4. RELATIONSHIP BETWEEN ALTERATIONS OF THE 
HYPOTHALAMUS-PITUTARY-THYROID (HPT) AXIS  AND  
SEROTONIN. 
 Evidence that serotonin, a neurotransmitter strongly involved in 
depressive states, also has a pathophysiological role in thyroid disease stems 
from several observations. Research by Cleare et al., (1996) have noticed 
that the hypothyroidism reduces central (5- HT) activity in the brain. They 
found a positive relationship between depressive scores and the increase in 
the TSH levels. They also suggest a threshold effect in that higher TSH 
levels predicted lower 5HT mediated endocrine responses and the presence 
of clinical depression. This same group of researchers, in a further 
investigations on the serotoninergic function in patients with 
hypothyroidism, have confirmed the previous findings and noticed that the 
serotononergic function was normalized by reposition therapy with thyroid 
hormones.  
Evidence for interaction of serotonin with thyroid hormone. Stems 
from following observation: 
1. The use of T3 can reduce the activity of the 5HT1A auto receptors 
and then increase the cortical release of 5HT.(AltshulerLL et 
al.,2001) 
2. Both in hypothyroidism and hyperthyroidism the functioning of 
thyroid hormone metabolizing enzymes can affect the brain levels 
of serotonin. 
3. Depression causes an inhibition of type II deiodiase enzyme leading 
to a decrease in the brain levels of T3 and contributing to the 
decrease of serotonin in depressive pictures (Nemeroff CB. et al., 
1989). 
Kirkegaard and Faber et al., 1998 believe that serotonin deficiency, a 
main pathogenic factor in depression is sufficient to explain the alterations 
in the HPT axis in depressed patients, especially endogenous ones. 
5. STRESSFULL LIFE EVENTS & DEPRESSION : Studies have 
shown that compared to healthy controls depressed patients have 
significantly greater number of life events prior (6-12 months) to the onset 
of their illness(Chatterjee RN.et al.,1981,Satija YK et al.,1998, Prakash et 
al.,1980) .In terms of type of life events, it is seen that depressed patients 
experience high proportion of life events related to death of family member, 
personal health related problem, bereavement, inter personal and social 
events(Chandran M et al.,2002,Chatterjee RN et al .,1981). 
 It is also seen that compared to patients with mild depression, patient 
with moderate and severe depression tend to use avoidance as coping 
strategies more frequently for the stressful life events, suggesting that it may 
be a   maladaptive way to cope with the situation, which is responsible for 
development of depression (Satija YK et al .,1998). 
6. INDIAN STUDIES: 
 An overview of Indian Research in depression was done by Grover 
S.et al.2010. 
Depression is a disorder of major public health importance in terms of 
its prevalence, suffering, dysfunction, morbidity and economic burden. The 
report on Global burden of Disease estimates the point prevalence of 
Unipolar depressive episode to be 1.9 % for men and 3.2 % for women. One 
year prevalence has been estimated to be 5.8 % for men and 9.5 % for 
women. 
Demographic and psychological risk factors for depression: 
 In terms of socio demographic variables, studies by (Sethi 
etal.,1979,Poongothai et al.,2009,Nandi DN et al.,1979, Bagadia VN et al., 
1973  Ramachandran V et al., 1982) have shown that depression is more 
common in women, in subjects with low socio economic background 
(Poongothai et al.,2009, Bagadia VN et al.,1973, Mohandas E et al.,2009) 
those who are divorced or widow (Poongothai et al.,2009) or those residing 
in urban areas(Reddy MV et al.,1998) . 
THYROID DYSFUNCTION: 
 Two studies by (Boral GG et al.,1980 and Saxena J et al.,2000 )have 
found that significantly higher number of patients with unipolar depression 
have subnormal T3 and T4 levels and a corresponding increase in TSH 
levels compared with healthy controls. 
 In a second study by Saxena J et al.,2000, mildly depressed patients 
had significantly lower TSH and severely depressed patients had higher 
TSH suggesting the direct relationship of severity of depression and TSH 
levels. Another study Gupta S et al.,2008 found that 20.5% subjects of 
major depressive disorders have hypothyroidism. A study by (Chopra VK et 
al.,2001) on drug naïve first episode depression patients showed 
significantly higher T4 levels, but there was no significant difference in the 
level of T3 and TSH between depressed and healthy control subjects. 
 When depressed subjects with and without psychotic features were 
compared, it was seen that subjects with psychotic symptoms had 
significantly higher levels of TSH. 
 Study by Gautam S. 2010 Hypothyroidism can cause depression, 
cognitive impairment and rapid cycling mood disorder. Subclinical 
hypothyroidism also cause an increased frequency of sub syndromic 
depression. 
SYMPTOMATOLOGY: One common theme with regard to 
symptomology of depression, which has been reported by most of the 
research, is high prevalence of somatic syndromes and several studies report 
that somatic symptoms are the most common manifestation of depression in 
Indian sub population. 
 Depression is the most common psychiatric disorder reported in most 
of the community based studies in India. Further studies from India has also 
shown that life events during the one year period preceeding the onset of 
depression plays a major role in depression. Studies on women also shows 
the importance of identifying risk factors like inter personal conflicts and 
marital disharmony and focusing an improving social network and psycho 
education may prevent the development of depression. 
There are several papers suggesting that the thyroid function of 
depressed patient is within the normal range, hypothyroidism and hyper 
thyroidism are extremely uncommon and that the presence of subtle thyroid 
function abnormalities does not have an impact on treatment outcome. 
(Joffe 1987;Harris et al.,1989; Fava et al.,1995; Joffe et al.,1996; pop et 
al.,1998). 
 However, on the contrary, there are even more papers supporting the 
idea of a sub clinical thyroid dysfunction, especially in melancholic or 
refractory patients, possibly of an auto immune origin (Banki et al.,1985; 
Kjellman et al.,1985; Nemeroff et al. ,1985;Gewirtz et al., 1988; Marchesi       
et al., 1988; Nemeroff 1989; Rao et al.,1989; Rupprecht et al.,1989; 
Howland 1993; Bunevicius et al.,1994; Maes et al .,1994;Rao et al .,1996) 
suggesting that subclinical hypothyroidism may lower the threshold for the 
occurrence of depression (Haggerty et al.,1993) or generally to any mental 
disorder (O’Donnel et al.,1998; Stein and Uhde 1989; Haggerty et al.,1990). 
Thus review of literature suggest that most patients with depression, 
although generally viewed as chemically euthyroid, may have alterations in 
their thyroid function (Joffe et al.,1992; Custro et al.,1994; De Mendonca 
Lima et al., 1996) including slight elevation of the serum FT4 (especially in 
melancholic patients) (Mades et al.,1993), blunted TSH response to 
thyrotropin releasing hormone(TRH) stimulation (Loosen 1985), and loss of 
nocturnal TSH rise, and this may reflect brain hypothyroidism in the context 
of systemic euthyroidism (Bauer et al.,1990; Jackson 1998; Sullivan et 
al.,1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 AIM AND OBJECTIVES 
Aim: 
To assess the basal thyroid functions in patients with first episode 
depression and to compare with controls 
Objectives: 
1. To assess the level of serum T3, T4, TSH in patients with first episode 
depression and  to compare with that of age & sex matched controls. 
2. To correlate the severity of depression and thyroid hormone level. 
3. To assess the relationship of socio-demographic profile with thyroid 
hormone level and severity of depression . 
4. Presumptive stressful life events and its impact on severity of depression 
and its relationship with thyroid hormone levels. 
Hypothesis: 
1. Serum T4 level is higher in depression compared to controls. 
2. Serum TSH level has no significant difference in depression compared to 
controls. 
3. Serum T3 and T4 level is significantly higher in severe depression 
compared to mild/moderate types. 
4. Subclinical hypothyroidism is more common in females than males. 
5. Stressful life events increases the severity of depression 
MATERIALS AND METHODS 
Inclusion Criteria: 
1. Age : 25-45years , male & female for both cases and controls. 
2. Patients diagnosed as Depressive disorder(according to ICD-10 DCR 
criteria)who are drug naïve & first episode as cases and controls 
selected based on those without present / past  physical or psychiatry 
illness. 
3. Patient who are cooperative and have given consent 
Exclusion Criteria 
1. Individuals with past history of psychiatric disorder 
2. Individuals with history of any systemic illness/substance abuse or 
dependence in the past or present 
3.  Patients & controls on any psychiatric medications 
4. Patients who have been already diagnosed as hypothyroid or 
hyperthyroid or on any thyroid medication. 
Methodology: 
Sample of 50,of whom 25 are newly diagnosed patients as Depressive 
episode and who are drug naïve presenting in our OP department and 
another 25 are controls are screened for thyroid function .Thyroid hormone 
level assessed after 12hrs fasting between 8am and 9am.They are assessed 
for cross sectional study 
Standard Tools: 
1. Proforma 
2. ICD-10 DCR criteria 
3. Hamilton rating scale for depression 
4. Presumptive stressful life event scale 
5. SES scale 
To asses the thyroid dysfunction in depression by assessment of basal 
thyroid hormone level. 
Operating design: 
1. The study is planned to be conducted between January 2011 to 
October 2011. 
2. Patients and controls who meet the above inclusion and exclusion 
criteria are chosen from Psychiatric OP and shown to Senior 
Psychiatrist and on his advice are included in the study 
3. Patients and controls are explained about the nature of the study and 
informed consent are obtained for inclusion in the study. 
4. Patients and controls have been assessed based on detailed history 
obtained from relaiable informant.Complete physical and 
neurological examination done & detailed mental status examination 
done.Biochemical investigations are being done in accredited 
lab.Clinical examination done on two sessions on consecutive days. 
5. All the above groups have been subjected to the above tools before 
starting the medication. 
Statistical design: 
Statistical design was formulated using the data collected as above, 
for each of the scales and sociodemographic variables the central values and 
dispersion were calculated. In comparison of the datas for categorical 
variables chi-square and for numerical variables student t test were used 
 
 
 
 
 
Tools Used : 
1.  Proforma 
Proforma includes personal demographic details,  personal history, 
past history, family history, physical and Mental  status examination and 
biochemical investigations. 
2. ICD-10 (DCR) :  the diagnostic criteria for research accompanying 
the ICD-10 (DCR) are designed for use in research ; their content is derived 
from the Glossary to the chapter on Mental and Behavioural Disorder in the 
“Clinical Descriptions and Diagnostic Guidelines” (CDDG) that have been 
produced for general clinical and educational use by psychiatrists and other 
mental health professionals (WHO 1992). 
3.  Hamilton Rating Scale for Depression (HAM-D): 
                     The Hamilton Rating Scale for Depression (HAM-D) is one of 
the most popular depression assessment instruments among the clinician 
scales in the field of Clinical and Health Psychology. The first version was 
published by Max Hamilton in 1960. He designed the scale as a measure of 
the severity of depression in previously diagnosed depressed inpatients 
(Hamilton, 1960). Since then different versions have been developed. 
Although people usually use the 17-item version, the original version had 
twenty-one items but Hamilton himself decided that the last four items 
(diurnal variation, depersonalization/derealization, paranoid symptoms, and 
obsessional and compulsive symptoms) should not be considered part of the 
disease, because they are not as frequent as the others and therefore should 
not contribute to the total score. There is another version in which three new 
items have been added, to make the 24- item version: helplessness, 
hopelessness, and worthlessness (Paykel, 1985; Rosenthal and Klerman, 
1966). 
              Hamilton depression scale has been the standard for the assessment 
of depression for more than 40 years. Many of the psychometric properties 
of the Hamilton depression scale are adequate and consistently meet 
established criteria. The internal, interrater, and retest reliability estimates 
for the overall Hamilton depression scale are mostly good, as are the 
internal reliability estimates at the item level. Similarly, established criteria 
are met for convergent, discriminant, and predictive validity, although the 
latter does suffer somewhat due to multidimensionality. At the item level, 
interrater and retest coefficients are weak for many items, and the internal 
reliability coefficients indicate that some items are problematic. The lack of 
individual item reliability is not necessarily a fatal psychometric flaw; what 
is critical is that the items as a whole provide adequate reliability. 
 
4.  PRESUMPTIVE STRESSFULL LIFE EVENT SCALE:   
Developed by Gurmeet Singh et al.(1983), it was constructed and 
standardized for use in the Indian population. It is a standardization of the 
Social Readjustment Rating Scale (SRRS).It is in the form of an inventory 
of 51 items, each item having a weighted stress score. For example death of 
spouse=100; going on pleasure trip=20, conflict over dowry=51.The items 
are further categorized as personal or impersonal events, desirable or 
undesirable or ambiguous events. It is administered in the form of a 
semistructured interview, wherein the events are assessed to be either 
present or absent.  
5.  Kuppuswami scale : (Socio-economic Status) 
Kuppuswami scale is widely used to measure the socio-economic status of an 
individual in urban community based on three variables namely education, occupation 
and income. The modification of Kuppuswami scale meant to determine the 
socioeconomic status of family based on education and occupation of head of the 
family and per capita income per month has also been widely used.  
Limitations of the Study : 
1. Being a cross sectional study with small sample size the findings 
derived may not reflect universal population. 
2. The higher mean (T4) levels noted in depressives significantly 
decreased with response to various treatments.  In this study, the level of 
thyroxin (T4) were not performed after the recovery and this remains one of 
its limitations. 
3. Further thyroid function tests like TSH response to TRH, CSF 
analysis of TSH levels, tests to determine nocturnal rise in TSH, thyroid 
autoantibodies are not done in our study, which would have given more 
insight about thyroid abnormalities in depressives. 
4. From our sample size, since none of the cases had psychosis, the 
findings of hormonal levels could not be ascertained in patients with 
psychotic depression. 
 
 
 
 
 
 
 
 
  
RESULTS AND INTERPRETATION 
 
Table 1 
Table showing Socio demographic profile of cases and controls 
 
 
Sl.No Variable 
Cases (N=25) 
n 
Controls (N=25) 
n 
P 
value 
1 
AGE 
0.77 
< 30 years 13 10 
31 - 40 years 7 12 
> 40 years 5 3 
2 
SEX 
1.0 Male 5 5 
Female 20 20 
3 
MARITAL STATUS 
0.5 Married 22 23 
Unmarried 3 2 
4 
RESIDENCE     
0.773 Rural 16 15 
Urban 9 10 
5 
SES 
0.157 Lower Middle 15 9 
Upper Middle 10 16 
 
 
 
 
 
 
          Table 1 shows the comparison of socio demographic variables 
between the depressive and the control groups. Majority of patients with 
depression (80%) were below 40 years and 88 % of controls were below 40 
years. 80% of both cases and controls in our samples were females. 
Majority of depressives (88%) and controls (92%) were married. More than 
2/3 of our sample in cases (64%) and controls (60%) belong to rural 
background. 60 % of depressive were of low socio economic status and 64 
% of controls were of middle socio economic status. There was no 
significant difference between the two groups with respect to age, sex, 
marital status, socio economic status and residence. 
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 Table 2 
Table showing Thyroid Hormone values of cases and controls 
 
Sl.No Variable Cases (N=25) n 
Controls (N=25) 
n P value 
1 
T3 value 
(60-200 ng/dl) 
0.2855      
< 200 ng/dl 25 25 
> 200 ng/dl 0 0 
Range 75-131 79-141 
Mean 105.4 102.1 
SD 15.8 15.6 
2 
T4 value 
(4.5-12 µg/dl) 
0.0041* 
≤ 12 µg/dl 22 25 
≥ 12 µg/dl 3 0 
Range 6.4-13 5.4-11.1 
Mean 9.83 8.45 
SD 1.7 1.25 
3 
TSH value 
(0.3-5.5  mIU/ml) 
0.3083    
≥ 5.5 2 0 
≤ 5.5 23 25 
Range 0.03-10.59 0.87 - 5.18 
Mean 2.36 2.27 
SD 2.32 1.13 
 
P <  0.05 *      P < 0.001** 
 Table 2 shows the comparison of total thyroxin (T4), total 
triiodothyronine (T3) and thyroid stimulating hormone (TSH) between the 
depressive and the control groups. Almost all patients with depression and 
controls had serum T3 value < 200 ng/dl. Mean T3 value for depressive was 
105.4 and for control was 102.1. The mean T3 value of both cases and 
controls were not significantly different. 
  Twenty two patients with depression (88 %) had serum T4 value 
within normal range and three patients had high T4 value. Among controls 
all had normal value. Mean T4 value for depression was 9.83 and for control 
was 8.45. The difference was higher in depressive group which was 
statistically significant.  
 Two patients with depression had higher TSH values (8 %) and rest 
of the patients and controls had normal TSH levels. There was no difference 
between the mean value of thyroid stimulating hormone (TSH) between the 
two groups. 
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 Table 3 
Table showing PSLE and PSLE scoring in cases and controls 
 
Sl.No Variable Cases (N=25) n 
Controls (N=25) 
n P value 
1 
PSLE 
0.0001 ** 
≤ 2 18 25 
≥ 2 7 0 
Range 
Mean 
SD 
1-4 
2.08 
1 
0-2 
0.92 
0.7 
2 
PSLE score 
0.0001 ** 
≤ 200 21 25 
≥ 200 4 0 
Range 
Mean 
SD 
47-247 
119 
58.3 
0-134 
49.8 
40 
 
[P < 0.05 *,  P <  0.001**] 
Table 3 shows the presumptive stressful life events in cases and 
controls. Seven depressive (28 %) had more than two life events in the past 
one year. The rest of the patients and controls had less than two life events 
in the past one year. The difference was statistically significant. The trend 
suggests stressful life events within one year significantly increase the onset 
of depression. 
 Four patients with depression (16 %) had presumptive stressful life 
event score more than 200, rest of the patients and controls had presumptive 
stressful life event score < 200. The mean PSLE score for depression was 
119 and for the control was 49.8 which shows statistically significant 
difference. 
 Table 4 
Table showing PSLE and Thyroid hormone values in MDD 
cases 
 
S.No. Variable Thyroid hormone values 
1 PSLE 
T3 T4 TSH 
Mean SD Mean SD Mean SD 
 
≤ 200 106.7 15.9 9.95 1.66 2.4 2.48 
>200 98.8 15 9.23 2 2.11 1.42 
‘p’ value 
 
0.2496 
 
 
0.4143 
 
 
0.9704 
 
 
Table 4 : Shows the relationship between presumptive stressful life 
events and the thyroid function values in depressives. The mean serum T3 
levels in patients with depression with life event score < 200 was 106.7 and 
more than 200 was 98.8 showing no statistical difference. On comparison of 
patients with less than 200 and more than 200 in presumptive stressful life 
event score in relation to serum T4 levels and serum TSH levels also did not 
show any statistical difference. 
 
 
 
 
 
 
Table 5 
Table showing Severity of depression in cases 
Depression severity 
Cases 
No % 
Mild 2 8 
Moderate 13 52 
Severe 5 20 
Severe with somatic syndrome 5 20 
Total 25 100 
 
Table 5 shows the severity of depression based on Hamilton rating 
scale for depression. Based on HAM-D scoring two patients (8%) had mild 
depression, 13 patients (52%) had moderate depression. Among patients 
with severe depression, 5 patients were categorized as severe depression 
with somatic syndrome. 
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Table 6 
Table showing relationship between socio Demographic variables and 
severity of depression 
Sl. 
No Variable 
Severity of Depression  
Mild Moderate Severe 
Severe with 
S.S P value 
No. % No. % No. % No. % 
1 
SEX 
0.3012 
Male 0 0 2 40 2 40 1 20 
Female 2 10 11 55 3 15 4 20 
2 
MARITAL STATUS 
0.6543 
Married 2 9.1 11 50 5 22.7 4 18.2 
Unmarried 0 0 2 66.7 0 0 1 3.3 
3 
SES 
0.0182* 
Lower Middle 1 6.7 11 73.3 2 13.3 1 6.7 
Upper Middle 1 10 2 20 3 30 4 40 
4 
RESIDENCE 
0.0533 
Rural 2 12.5 10 52.5 2 12.5 2 12.5 
Urban 0 0 3 33.3 3 33.3 3 33.3 
 
[P <  0.05 *, P <  0.001**] 
Table 6 shows the relationship between socio demographic variables 
and severity of depression. Depression severity and age of patients did not 
have any significant relationship. It shows that among five males with 
depression two belong to moderate and three belong to severe category. 
Among twenty females, two had mild, eleven had moderate and seven had 
severe depression, but the difference was not significant. Among depressive 
twenty two were married and three were unmarried and majority of married 
(44%) had moderate depression, nine patients (36 %) had severe depression. 
Severity of depression was not affected by the marital status of patients. 
  
 Regarding socio economic status fifteen patients 60% belong to low 
socio economic status and ten patients belong to middle socio economic 
status. Among patients with low socio economic status eleven patients 
(73.3%) had moderate depression and three patients (20%) had severe 
depression. Among middle socio economic status two patients (20%) had 
moderate depression and seven patients had (70%) had severe depression. 
The difference is statistically significant. No difference was noted in 
comparison between residential status and severity of depression. 
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 Table 7 
Table showing  Severity of depression and thyroid hormone values 
 
S.No. Variable Thyroid hormone values 
1. Severity of depression 
T3 (ng/dl) T4 (µg/dl) TSH(mIU/ml) 
Mean SD Mean SD Mean SD 
 Mild 83.5 4.9 7.55 0.64 0.74 0.12 
Moderate 103.5 16 9.68 1.64 2.2 1.81 
Severe 109.2 15.5 10.27 1.36 2.73 1.25 
Severe with somatic 
syndrome 
115.2 9.5 10.7 1.83 3.02 4.33 
‘p’ value 0.0234* 0.0301* 0.2317                          
 
[P <  0.05 *, P <  0.001**] 
Table 7 shows the relationship between severity of depression and 
thyroid function values. The mean T3 level in mild depression is 83.5 and 
increases as the severity of depression increases with mean T3 in patients 
with severe depression with somatic syndrome was 115.2. As severity of 
depression increases mean T3 value also increases which was statistically 
significant. The same trend was noted in relation to serum T4 level with 
significantly high T4 levels in severe depression compared to mild or 
moderate depression. On comparison of TSH level, even though TSH values 
vary with severity of depression, the relationship was not statistically 
significant. 
 
 
 
 
Table 8 
Table showing Depression severity and PSLE score 
 
Depression severity PSLE Score P value 
Mean SD  
 
0.0408 * 
Mild 193.5 26.2 
Moderate 97.9 40.5 
Severe 163 68.8 
Severe with somatic 
syndrome 
100.2 59.2 
 
[P <  0.05 *, P <  0.001**] 
  Table 8 shows the relationship between the severity of 
depression and presumptive stressful life event score. On comparison of life 
event scoring and severity of depression, mean score for mild and severe 
depression was significantly higher than moderate and severe depression 
with somatic syndrome. 
 
 Table :9 
Table showing Socio demographic characteristics and thyroid profile 
Characteristics Thyroid Profile 
T3 T4 TSH 
Mean S.D. Mean S.D. Mean S.D. 
AGE 
Upto 25 107.7 11.4 9.8 2.18 3.43 3.92 
26-30 109.1 13.6 9.99 1.44 2.09 1.65 
31-35 101.5 23.9 9.63 2.59 0.98 1.13 
36-40 100.7 28.5 8.93 1.19 1.5 0.01 
41-45 103.4 12.4 10.36 1.22 3.04 2.26 
‘p’ value 0.736 0.8083 0.2844 
SEX 
Male 103 12.1 9.29 2.06 4.4 3.57 
Female 106 16.8 9.97 1.63 1.84 1.66 
‘p’ value 0.5398 0.4751 0.0351 * 
MARITAL STATUS 
Married 106 16.4 10.03 1.62 1.91 1.63 
Unmarried 101 11.5 8.4 1.87 5.62 4.31 
‘p’ value 0.476 0.1429 0.0365 * 
RESIDENCE 
Rural 107.4 15.1 9.87 1.7 2.6 2.74 
Urban 101.9 17.2 9.77 1.8 1.92 1.31 
 SOCIAL CLASS 
Lower middle 104.4 18.2 10.17 1.72 1.79 1077 
Upper Middle 106.9 12.0 9.33 1.61 3.2 2.86 
‘p’ value 0.9114 0.2218 0.1341  
P <  0.05 *       P < 0.001** 
Table 9 : It shows the relationship between sociodemographic 
characteristics and thyroid profile. It shows no significant relation existing 
between age, residence and social class in relation to serumT3,T4 and TSH 
levels. On comparison of sex and serum TSH levels there is a significantly 
high TSH in men compared to women but no relationship seen between 
serum T3, serum T4 levels and sex.  
Since the elevation of TSH level is within normal limits, the results 
do not reflect underlying subclinical hypothyroidism between sex. 
On comparison of marital status and serum TSH levels there is a 
significantly high serum TSH in married person, but no correlation seen 
between T3,T4 and marital status. 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
                 The aim of the study is to assess the thyroid dysfunction in 
depression by assessment of basal thyroid hormone level. 
                The present study included only drug-naive patients having first 
episode of depressive illness. This way, the nonspecific effects of chronicity 
of illness and pharmacological agents on thyroid functions were taken care 
of. In our study we found that depression was more common in women, 
people from rural background and in younger individuals. 
 
               The most significant finding of our study was elevated levels of 
total thyroxin (T4) in the depressive patients in the acute phase of illness as 
compared to healthy controls. This is in agreement with most of the earlier 
studies (Whybrow et al.,1972; Takahashi et al.,1974; Kirkegaard and 
Faber,1981; Muller and Boning, 1988).V K Chopra .,et al 2001. 
 
 Bauer and Whybrow (1988) proposed that elevated total thyroxin 
(T4) during acute depression is a compensatory phenomenon so as to help in 
increasing the catecholamine neurotransmission for the alleviation of 
depressive affect. According to Jackson et al.,1999 most patients with 
depression although generally viewed as chemically euthyroid, have 
alterations in their thyroid function  which includes slight elevation in their 
serum thyroxine level. He postulated that hypercortisolism of depression 
leads to elevated T4 in some depressives. 
According to Joffe.,et al 1990 the most consistent finding in acute 
depression was elevated total thyroxin T4 or free thyroxin Ft4 within the 
euthyroid range. 
         Joffe.,et al. (1984) and Joffe and Levitt (1990) proposed that relative 
increase in total thyroxin (T4) during acute depression is not compensatory, 
but is pathological indicating a relative state of hyperthyroidism and a 
substantial decrease in thyroxin level is required for recovery. Moreover 
significant decrease in T4level occurs with response to various treatments, 
including antidepressant, (Joffe RT & Levitt AJ.,et al 1993) (Bauer MS & 
Whybrow PC et al.,1988) (Kirkegaard C & Faber J etal.,1981), electro- 
convulsive therapy (Kirkegaard C & Faber J et al.,1986), and cognitive 
behaviour therapy (Joffe RT & Singer W.,et al 1996)   
In our study, the levels of thyroxin (T4) were not preformed after the 
recovery and this remains one of its limitations. 
  Most of the studies of major depressive disorder have found an 
relative increase (ie. Within the normal range) in iodothyronine (most 
notably hyprethyroxinemia ie. FT4 or total T4). Neurobiologically this 
thyroid alterations has been proposed to represent a compensatory 
mechanism to a pathological process that is depression or the primary 
pathology itself. 
In our study we did not find any difference with respect to thyroid 
stimulating hormone (TSH) levels between the depressives and the control 
groups, although TSH values increased with the severity of the depression it 
was not statistically significant. This finding is similar to most of the 
previous studies(Takahashi et al.,1973;Linnollaet al.,1979;Gold et 
al.,1981;Loosen&Prange 1982).  
 
 Cleare., et al 1996 found a positive correlation between depressive 
scores and the increase in TSH levels. A probable hypothesis for the 
increase in TSH in depression may be due to reduction in somatostatin as 
found by( Rubinow DR.,et al 1983 &Bissette G .,et al 1986) ,which 
normally inhibits the release of TSH from the hypophysis. 
 
A study by Saxena J., et al 2000,found mildly depressed patients had 
significantly lower TSH and severely depressed patients had higher TSH 
suggesting the direct relationship of severity of depression and the TSH 
levels.  
Regarding T3, we did not find any difference with respect to mean 
value of total triiodothyronine (T3) between depressives and controls.                                                                                            
             The literature regarding total triiodothyronine (T3) during acute 
depression is less consistent. Takahashi et al. (1974) found marginally 
elevated T3 during acute depression whereas most of the other studies 
reported either normal or decreased total T3 during acute depression 
(Kirkegaard and Faber,1981; 
 
Kjellmanetal.,1983; Sternback etal.,1985; Joffe et al., 1985; Orsulak 
et al., 1985; Baumgartner et al.,1988). Muller and Boning (1988) found 
elevated thyroxin (T4) and decreased triiodothyronine (T3) during acute 
depression and concluded that this finding may indicate that there is some 
defect in the conversion of thyroxin (T4) to triiodothyronine (T3).According 
to Nemeroff.,et al 1989 noted defect in brain deiodinase can be a pathogenic 
factor in depression, which prevents conversion of T4 into active T3 in brain 
raising the possibility of central or brain hypothyroidism in the context of 
systemic euthyroidism. 
 
               Regarding the relationship between severity of depression and 
thyroid dysfunction in our study we found that the mean T3&T4 levels 
significantly increased as the severity of the depression increased. Even 
though the TSH levels also increased with the severity of the depression it 
was not statistically significant. 
               Joffe et al. (1992) did not find any difference between patients 
with melancholic and non-melancholic depression with respect to total 
thyroxin (T4), total triiodothyronine (T3) and thyroid stimulating hormone 
(TSH). In a study by Chopra VK et al, 2001 he did not find any difference 
with respect to any of the thyroid parameters between the depressive 
patients with and without the presence of somatic syndrome.  
 
          Fountaulakis., et al 2004 in his study he concluded that no significant 
differences can be traced concerning the thyroid function between clinical 
subtypes of depression nor any correlation between specific clinical 
symptoms and thyroid indices. 
 
             Apart from subtle changes in the thyroid functions, many studies 
have found overt thyroid abnormalities in a minority of depressive patients 
(Goldetal.,1981; Diaz-Cabaletal.,1986; Joffe et al.,1992).  
 
             We found a total of a 2 (8%) patients have grade II (Gold et 
al.,1981) subclinical hypothyroidism as suggested by elevated the TSH level 
and 2 patient (8%) having frank hyperthyroidism as suggested by elevated 
T4 level above normal values. According to Haggerty Jr .,et al 1993 the life 
time frequency of depression was significantly higher(56%) in subjects with 
subclinical hypothyroidism than who did not (20%), suggesting that 
subclinical hypothyroidism  may lower the threshold for depression. 
According to (Woodbury 1918: Brown-lie et al 2000) that in patients with 
hyperthyroidism depression can be prominent and found with symptoms of 
agitation rather than retardation. Kathol et al (1986) found that almost one –
third of 29 consecutive patients seen in an endocrine clinic met criteria for 
major depression. 
 
            Considering the impact of stressful life events within one year of the 
onset of depression we found that depressives had significantly more life 
events than controls suggesting that stressful life events within one year 
significantly increase the onset of depression. This finding is similar to the 
previous studies (Grover et al.,2010). Several studies (PayKel et al., 
1969:Cadoret 1972, Bidzinksa 1984) have documented that life events are 
very well associated with the onset of depressive disorders. Indian workers 
(Prakash.,et al1980,Chatterjee .,et al 1981)have found that depressives 
experience numerically more life events .In study by Suresh Kumar PN., et 
al although life events were significantly more in depressives, however there 
was no relationship between the severity of life events and the magnitude of 
illness in depressives. A Study by Niruj Agrawal & H.P.Jhingan 2002  
reported that severity of depression was not found to be associated with 
significantly higher life events, which showed that life event are associated 
with the occurrence of depression and not its severity. 
This is consistent with our study where we found that even though 
depressives had significantly more life events it had no relationship with the 
severity of depression.   
In the conclusion, we would like to emphasize that this study supports 
the view that there are subtle but significant abnormalities in the basal level 
of thyroid hormones in acute depressive illness. There is a need to continue 
the research efforts in this field to further clarify the aetiological 
significance of altered thyroid functioning in depressive illness. 
 
Based on our finding it has been found that depression is common in 
younger age, women and those who are from rural background. On 
comparison of sociodemographic matched controls it has been found that T4 
values was significantly higher in depressives compared to controls, but 
similar trend was not found with respect toT3&TSH levels. There has been 
a significantly higher occurrence of stressful life event and stressful life 
event scoring in depressive patients in the preceeding one year before the 
onset of illness. No significant correlation has been noticed between 
stressful life events and thyroid hormone values. 
          
        Majority of the sample were classified as having moderate and one 
fifth each as severe depression with somatic syndrome and severe 
depression without somatic syndrome. No significant relationship was 
observed on comparison of sociodemographic variable with relation to 
severity of depression except socioeconomic status. Severity of depression 
has been significantly related to serum T3&T4 levels, but not with TSH 
levels. No significant relationship between severity of depression and life 
event scoring. On comparison of sociodemographic profile and thyroid 
hormone level,  there has been a significantly higher TSH level were found 
in men and those who are unmarried. The higher TSH level was within 
normal limits and hence in our study no significant difference noted 
between sex in relation to possible subclinical hypothyroidism.  
 
 
 
 
 
 
 
 CONCLUSION 
Based on the detail analysis of depressives and controls the 
following conclusions are made: 
1. Serum T4 level is significantly higher in depressives than 
controls. 
2. Serum TSH level did not show significant difference between the 
depressives and controls. 
3. Serum T3 &T4 level has been significantly rising with the 
severity of the depression.  
4. Subclinical hypothyroidism did not show significant relation 
with sex.  
5. Stressful life events has been significantly higher in the 
preceding one year to onset of depression but did not consistently 
increase with the severity of depression. 
 
Future studies can be aimed at doing basal thyroid functions in 
all dimensions of depression including psychotic, bipolar and 
puerperal depression, which will enlighten the possible thyroid 
dysfunction in patients with depressive disorder.   
  Further follow up studies will help in understanding the 
possible association of thyroid abnormalities in depressive disorder, 
their possible relationship with prognosis, treatment implications 
and treatment resistant depression. 
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PRESUMPTIVE STRESSFUL LIFE - EVENTS SCALE 
Name         Age Sex 
1. Going on a pleasure trip or pilgrimage(20)   () 
2. Wife begins or stops work (25)     () 
3. Change in eating habits(27)      () 
4. Change in Social Activities(28)     () 
5. Reduction in number of family function(29)   () 
6. Gain of new family member(30)     () 
7. Birth of Daughter(30)       () 
8. Change in Sleeping habits (33)     () 
9. Change in working conditions or transfer(33)   () 
10.  Retirement(35)        () 
11. Begin or end schooling(36)       () 
12. Outstanding personal achievement(37)    ()  
13. Change or expansion of business(37)      () 
14. Change in residence(39)        () 
15. Unfulfilled commitments(40)       () 
16. Trouble with neighbour(40)       () 
17. Getting married or engaged(43)      () 
18. Appearing for examinations or interview(43)   () 
19. Failure in examination(43)      () 
20. Death of pet(44)        () 
21. Major purchase or construction of house(46)   () 
22. Breakup with friend(47)       () 
23. Family conflict(47)        () 
24. Minor violation of Law(48)      () 
25. Marriage of daughter or dependent sister(49)   () 
26. Large Loan(49)        () 
27. Lack ofson(51)        () 
28. Self or family member unemployed (51)    () 
29. Sexual problems(5 1)       () 
30. Conflict over dowry (self or spouse) (51)    () 
31. Pregnancy of wife (wanted or unwanted) (54)   () 
32. Prophecy of astrologer or palmist etc.(59)    () 
33. Trouble at work with colleague, superiors or subordinates(52) () 
34. Illness of family member (52)      () 
35. Financial loss or problems(54)      () 
36. Son or daughter leaving home(55)     () 
37. Major personal illness or injury (56)     () 
38. Broken engagement or love affair(57)     () 
39. Conflict with in-laws (other than dowry) (57)   () 
40.Robberyortheft (59)        () 
41. Excessive alcohol or drug use by family member(58)  () 
42. Death of friend (60)       () 
43. Property or crops damaged (61)      () 
44. Marital Conflict (64)       () 
45. Death of close family member(66)     () 
46. Lack of child(67)        () 
47. Determination in Jail of Self or close family member(78) () 
48. Suspension or dismissal from Job (76)    () 
49. Marital Separation / divorce (77)     () 
50. Extra marital relation of spouse (80)     () 
51. Death of spouse (95)       () 
Total number of life events present      () 
Total Score -         () 
Up to 40 No stress 
41-200 Less / moderate stress 
>200 Severe stress 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 A STUDY OF BASAL THYROID FUNCTIONS IN DRUG NAIVE                    
FIRST EPISODE DEPRESSION   
SOCIODEMOGRAPHIC AND CLINICAL DATA: 
NAME:                                                    AGE:                         SEX: F/M 
ADDRESS: 
 
EDUCATION:                    ILLITRATE/upto10th/more than 10th 
RURAL/URBAN: 
MARITAL STATUS: 
OCCUPATION:   
SOCIO ECONOMIC STATUS:        LOW/MIDDLE/UPPER 
INFORMANT: 
SYMPTOMS: 
HOPI: 
PAST H/O: 
         Previous H/O Psychiatric illness: 
          Treatment History: 
          Systemic illness: 
Family H/O: 
            H/O psychiatric illness: 
            Medical illness: 
Personal H/O: 
Menstrual  History: 
Substance Use: 
Marital H/O: 
Premorbid Personality: 
G/E: 
Vitals: 
Anemia/jaundice/Goiter 
 
Systemic Examination: 
                                CVS: 
                                  RS: 
                                P/A: 
                               CNS: 
MSE : 
ICD10 (DCR) Diagnosis : 
Blood and Urine Investigations : 
Serum T3 level 
    T4 level 
    TSH level 
 
 
 
 
 
 
HAMILTON     DEPRESSION   SCALE 
1.   Depressed mood  
  Sad, hopeless, helpless, worthless  
0 = Absent 
1 = Gloomy attitude, pessimism, hopelessness 
2 = Occasional weeping  
3 = Frequent weeping  
4 = Patient reports highlight these feelings states in his/her spontaneous 
verbal and   non-verbal communication.  
2.Feelings of guilt   
0 = Absent 
1 = Self-reproach, feels he/she has let people down 
2 = Ideas of guilt or rumination over past errors or sinful deeds  
3 = Present illness is punishment  
4 = Hears accusatory or denunciatory voices and/or experiences 
threatening visual hallucinations.  Delusions of guilt.  
3.Suicide   
0 = Absent 
1 = Feels life is not worth living 
2 = Wishes he/she were dead, or any thoughts of possible death to self 
3 = Suicide, ideas or half-hearted attempt  
4 = Attempts at suicide (any serious attempt rates 4)  
4.Insomnia, early  
0 = No difficulty falling asleep 
1 = Complaints of occasional difficulty in falling asleep i.e. more than 
half-hour  
2 = Complaints of nightly difficulty falling asleep 
5.Insomnia, middle  
0 = No difficulty 
1 = Patient complains of being restless and disturbed during the night 
2 = Walking during the night – any getting out of bed rates 2 (except 
voiding bladder)  
6.Insomnia, late  
0 = No difficulty 
1 = Waking in the early hours of the morning but goes back to sleep  
2 = Unable to fall asleep again if he/she gets out of  bed 
 
7.Work and activities   
0 = No difficulty 
1 = Thoughts and feelings of incapacity related to activities: work or 
hobbies  
2 = Loss of interest in activity – hobbies or work – either directly 
reported by patient or indirectly seen in listlessness, in decisions and 
vacillation (feels he/she has to push self to work or activities)  
3 = Decrease in actual time spent in activities or decrease in 
productivity.  In hospital, rate 3 if patient does not spend at leas three 
hours a day in activities  
4 = Stopped working because of present illness.  In hospital rate 4 if 
patient engages in no activities except supervised ward chores  
 
8.Retardation 
Slowness of thought and speech; impaired ability to concentrate; 
decreased motor activity  
0 = Normal speech and thought  
1 = Slight retardation at interview  
2 = Obvious retardation at interview  
3 = Interview difficult  
4 = Interview impossible  
 
9.Agitation 
0 = None  
 1 = Fidgetiness  
2 = Playing with hands, hair, obvious restlessness  
3 = Moving about; can’t sit still  
4 = Hand wringing, nail biting, hair pulling, biting of lips, patient is on 
the run 
10.Anxiety, psychic   
Demonstrated by: 
0-No difficulty 
1-  subjective tension and irritability, loss of concentration 
2- worrying about minor matters  
3- apprehension  
4-  fears expressed without questioning  
5- feelings of panic  
6- feeling jumpy  
0 = Absent 
1 = Mild 
2 = Moderate 
3 = Severe  
4 = Incapacitating  
11.Anxiety, somatic 
Physiological concomitants of anxiety such as: 
•  gastrointestinal: dry mouth, wind, indigestion, diarrhea, cramps, 
belching 
•  cardiovascular: palpations, headaches 
•  respiratory: hyperventilation, sighing 
•  urinary frequency 
•  sweating 
•  giddiness, blurred vision 
•  tinnitus  
0 = Absent 
1 = Mild 
2 = Moderate 
3 = Severe  
4 = Incapacitating  
12.Somatic symptoms: gastrointestinal  
 0 = None  
1 = Loss of appetite but eating without encouragement  
2 = Difficulty eating without urging.  Requests or requires laxatives or 
medication for GI symptoms 
13.Somatic symptoms: general  
 0 = None  
1 = Heaviness in limbs, back or head; backaches, headaches, muscle 
aches, loss of energy, fatigability 
2 = Any clear-cut symptom rates 2  
14.General Symptoms 
Symptoms such as: loss of libido, menstrual disturbances  
 0 = Absent 
1 = Mild 
 2 = Severe  
15.Hypochondriasis  
0 = Not present  
1 = Self-absorption (bodily) 
2 = Preoccupation with health 
3 = Strong conviction of some bodily illness  
4 = Hypochondrial delusions 
     
16.Loss of weight 
0 = No weight loss  
1 = Probable weight loss associated with present illness  
2 = Definite (according to patient) weight loss  
 
B  Actual weight changes (weekly):  
17.  Insight  
0  =  Acknowledges being depressed and ill  
1  =  Acknowledges illness but attributes cause to bad 
food,  
  overwork, virus, need for rest, etc.  
2  =  Denies being ill at all  
     
  
HAMD – SCORE INTERPRETATION 
 
  0 – 7  - None / minimal depression 
  8 – 17 - Mild 
  18 – 25 - Moderate 
   > 25   - Severe 
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ABSTRACT 
Objective: To assess the basal thyroid functions in drug naive patients with first 
episode depression. 
Methods: Sample of 50 , of whom 25 are newly diagnosed as depressive 
disorder according to ICD-10 DCR, who are drug naive and equal number of 
healthy, age and sex matched controls were included in this study. HAM-D scale 
was used to classify the degree of depression into mild, moderate and severe 
grades. The thyroid hormone levels (T3,T4 & TSH) were estimated. The PSLE scale 
was used to assess the impact of stressful life events on the onset and severity of 
depression. The data were analyzed using chi-square for categorical variables and 
student ‘t’ test for numerical variables. 
Results: Serum T4 level is significantly higher in depressives than controls. Serum 
T3 and T4 level has been significantly rising with the severity of depression. 
Stressful life events has been significantly higher in the preceding one year to 
onset of depression. 
 Conclusion: This study points towards  a significant but subtle abnormalities in 
the thyroid functions in depressed patients. Thus inclusion of thyroid screening 
test among depressives may be helpful in assessing their possible relationship 
with prognosis, treatment implications and treatment resistant depression. 
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